BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 12471147)

  • 21. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis.
    Weir C; Bernard CC; Bäckström BT
    Int Immunol; 2003 Nov; 15(11):1283-9. PubMed ID: 14565926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.
    Zaheer S; Wu Y; Sahu SK; Zaheer A
    Neurobiol Dis; 2010 Dec; 40(3):593-8. PubMed ID: 20696246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
    Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
    J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
    Calida DM; Constantinescu C; Purev E; Zhang GX; Ventura ES; Lavi E; Rostami A
    J Immunol; 2001 Jan; 166(2):723-6. PubMed ID: 11145641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
    Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
    Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis.
    Johnson DA; Amirahmadi S; Ward C; Fabry Z; Johnson JA
    Toxicol Sci; 2010 Apr; 114(2):237-46. PubMed ID: 19910389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR
    Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.
    Becher B; Durell BG; Noelle RJ
    J Clin Invest; 2003 Oct; 112(8):1186-91. PubMed ID: 14561703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.
    Wu Z; Nagano I; Asano K; Takahashi Y
    Parasitol Res; 2010 Oct; 107(5):1173-88. PubMed ID: 20661746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.
    Okuda Y; Sakoda S; Bernard CC; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
    Int Immunol; 1998 May; 10(5):703-8. PubMed ID: 9645618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of experimental autoimmune demyelination in complement-deficient mice.
    Nataf S; Carroll SL; Wetsel RA; Szalai AJ; Barnum SR
    J Immunol; 2000 Nov; 165(10):5867-73. PubMed ID: 11067947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.